Karsten Juhl

This inventor holds 54 USPTO granted patents and 14 published patent applications, plus 4 CIPO patents and 25 EPO patents, primarily in PDE1 Inhibitors (CPC class C07D). Top assignees: H. Lundbeck A/s, Other. Active years: 2009-2026.

USPTO Granted Patents = 54 (Patent Applications = 14)

% Patents Active = 53.7

CIPO Patents = 4 (Patent Applications = 13)

EPO Patents = 25 (Patent Applications = 36)

Average Co-Inventor Count = 5.0

ph-index = 7

Forward Citations = 174(Granted Patents)

Forward Citations (Not Self Cited) = 65(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Valby, DK (2018 - 2020)
Greve, DK (2009 - 2023)

Company Filing History:

52 out of 511

H. Lundbeck A/s

patents

2 out of 834,307

Other

patents

Years Active: 2009-2026

Loading Chart...

Areas of Expertise:

PDE1 Inhibitors

BACE1 Inhibitors

Hyperphosphorylated Tau

Pyrazolo Compounds

Imidazo Compounds

Combination Treatments

Macrocycles

Alzheimer's Disease

Antibodies

Isoquinolinone Derivatives

Triazine Backbone

54 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12590106 - Spiromacrocyclic orexin 2 receptor agonists (2026-03-31),

2. 12129289 - Antibodies specific for hyperphosphorylated tau and methods of use thereof (2024-10-29),

3. 11851425 - Combination treatments comprising administration of 1H-pyrazolo[4,3-B]pyridines (2023-12-26),

4. 11634416 - Combination treatments comprising administration of 1H-pyrazolo[4,3-b]pyridines (2023-04-25),

5. 11535611 - Pyrazolo[3,4-B]pyridines and imidazo[1,5-B]pyridazines as PDE1 inhibitors (2022-12-27),

6. 11491140 - 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors (2022-11-08),

7. 11472810 - Imidazopyrazinones as PDE1 inhibitors (2022-10-18),

8. 11111290 - Antibodies specific for hyperphosphorylated tau and methods of use thereof (2021-09-07),

9. 11104680 - 1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-ones and 1,5-dihydro-4H-pyrazolo[4,3-c]pyridin-4-ones as PDE1 inhibitors (2021-08-31),

10. 11026924 - 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors (2021-06-08),

11. 11026923 - 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors (2021-06-08),

12. 10912773 - Combinations comprising substituted imidazo[1,5-a]pyrazinones as PDE1 inhibitors (2021-02-09),

13. 10905688 - Combinations comprising substituted imidazo[1,5-α]pyrazinones as PDE1 inhibitors (2021-02-02),

14. 10858362 - Imidazopyrazinones as PDE1 inhibitors (2020-12-08),

15. 10806718 - 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors (2020-10-20),

Title: The Innovative Mind of Karsten Juhl

Introduction: Karsten Juhl, a talented inventor hailing from Greve, Denmark, is known for his groundbreaking contributions to the world of innovation.

Latest Patents: Karsten Juhl has recently been granted several patents for his cutting-edge inventions in the fields of renewable energy and sustainable technology.

Career Highlights: Throughout his illustrious career, Karsten Juhl has demonstrated a remarkable ability to transform creative ideas into tangible solutions that address pressing global challenges. His work has not only earned him recognition within the industry but has also positively impacted society as a whole.

Collaborations: Karsten Juhl has collaborated with leading research institutions and universities to further develop his inventions and bring them to market. His partnerships have been instrumental in pushing the boundaries of innovation and driving progress in various sectors.

Conclusion: In conclusion, Karsten Juhl stands as a beacon of inspiration in the world of inventors, showcasing the power of creativity, dedication, and collaboration in driving meaningful change. His contributions continue to shape the landscape of innovation, making the world a better place for future generations.